NCT05440409
- Conditions
- Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +14 more
- Locations
-
- National Cancer Institute (NCI) Bethesda, Maryland, United States
Clinical trial condition
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Explore clinical trials studying Precursor Cell Lymphoblastic Leukemia-Lymphoma. Study availability and eligibility vary by location and protocol.
1,800 public trials
303 recruiting studies
Precursor Cell Lymphoblastic Leukemia-Lymphoma trial results
NCT04252508
- Conditions
- Anxiety, Anxiety Disorders, Hematologic Diseases, +13 more
- Locations
-
- Plateau technique Centre François-Xavier Michelet Bordeaux, France
NCT03249870
- Conditions
- Acute Lymphoblastic Leukemia (ALL) - Philadelphia Chromosome (Ph)-Negative CD22+ B-cell Precursor (BCP), Chromosome Aberrations, Hematologic Diseases, +14 more
- Locations
-
- CH Amiens sud Amiens, France
- CHU Angers Angers, France
- CH Victor Dupouy Argenteuil, France
- CH cote basque Bayonne, France
NCT00081874
- Conditions
- Bone Marrow Diseases, Chronic Disease, Disease Attributes, +26 more
- Locations
-
- M.D. Anderson Cancer Center Houston, Texas, United States
NCT05818644
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Hepatic Artery Stenosis, +12 more
- Locations
-
- University Medical Center Groningen Groningen, Netherlands
NCT07644351
- Conditions
- Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- Novartis Investigative Site Boston, Massachusetts, United States
- Novartis Investigative Site Sydney, New South Wales, Australia
- Novartis Investigative Site Montreal, Canada
- Novartis Investigative Site Hong Kong, China
Completed
MRD Detection by NGS in Pediatric T-ALL
NCT06525116
- Conditions
- Acute Lymphoblastic Leukemia, Pediatric, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- The Children's Hospital of Zhejiang University School of Medicine Hangzhou, Zhejiang, China
NCT00534430
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +27 more
- Locations
-
Not specified
NCT02220985
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage, +57 more
- Locations
-
- University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT05296096
- Conditions
- Atrophy, Behavior, Hematologic Diseases, +22 more
- Locations
-
- Johns Hopkins Hospital Baltimore, Maryland, United States
- Boston Children's Hospital Boston, Massachusetts, United States